RCBC Earnings Due Amid Short Build and Index Inclusion Tailwind
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
RCBC heads into its October 26 earnings print with two forces pulling in opposite directions: short sellers rebuilding positions at pace while a credible Russell 2000 inclusion story supplies a mechanical buying argument.
The short build is the week's sharpest data point, though context matters. Shares short have roughly tripled over the past month, jumping another 43% in the past week alone to around 256,000 shares. That sounds dramatic until you note the absolute level: it remains tiny relative to the float. Availability has tightened from above 1,000% a month ago to 284% now, meaning roughly three shares remain available for every one already borrowed. Cost to borrow has actually eased, falling to 2.1% from above 4% in mid-September. The ORTEX short score has moved from 38 to 48 over ten days, a real shift, but still sits mid-range. The pattern looks like a small number of traders putting on watchful hedges ahead of a debut print, not a conviction short.
The index story runs the other way. ORTEX forecasts a 76% probability of RCBC joining the Russell 2000 at the December 2026 Semi-Annual Review, with the rank date falling on October 30 and an announcement expected November 13. The company's market cap of $772 million sits 83% above the entry threshold, so the qualification question is not close. Passive trackers would need to buy an estimated $21 million of stock around the December 11 trade date, equivalent to 4.7 days of normal volume. Among 655 similar historical additions, the median move from announcement to effective was minus 4%, with 55% moving the expected way: history is mixed, and the flow is mechanical, not a directional call.
The analyst picture has not moved since late August, when three firms started coverage simultaneously. Raymond James came in at Outperform with a $56 target, DA Davidson at Neutral with $55, and Stephens at Equal-Weight with $54. With the stock at $55.17, the mean target of $56 implies almost no upside. That cluster of initiations was the bank's first formal Street coverage as a public company. None has updated since. The PE multiple has drifted up about 8% over the past month to just over 11 times, and price-to-book has followed, rising to 1.19 times. Neither is stretched for a regional bank, but the direction of travel is toward a fuller valuation at the same time earnings risk is highest.
Ownership concentration is worth flagging. The top two holders, Shawn Kelly Devlin and the S. Kelly Marital Trust II, together account for more than 42% of shares. Both reduced positions significantly in recent reporting periods, Devlin by 1.35 million shares and the trust by the same amount. That kind of insider-linked selling at this scale in a newly public small-cap bank bears watching alongside the earnings release, since continued reduction would absorb demand.
The next test is the October 26 print itself. The prior quarter's result saw the stock rise 3.3% the following day. The quarter before that produced a 0.75% gain with a 2.1% fade over the subsequent five days. Two data points is thin, but the reaction function has been muted both ways. With the Street still finding its footing on estimates and major holders reducing, the focus will fall on deposit trends and net interest margin direction rather than whether the headline number beats.
Stocks in this article
See the live data behind this article on ORTEX.
Open RCBC on ORTEX →How this article was generated
- Generated
- 24 Oct 2026, 20:21
- Data as of
- 24 Oct 2026, 20:20
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesIndex RebalancePrevious Mi Articles
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.